1. Effect of anesthetic technique on antitumor immunity in patients undergoing surgery for gall bladder cancer: A prospective randomized comparative study.
- Author
-
Sharma A, Kumari L, Ratre BK, Khan MA, Kumar S, Deepak RK, Kumar V, Gupta N, Garg R, Mishra S, Bhatnagar S, and Bharati SJ
- Subjects
- Humans, Female, Male, Middle Aged, Prospective Studies, Aged, Transforming Growth Factor beta blood, Pilot Projects, Anesthesia, General methods, Adult, Anesthetics, Intravenous administration & dosage, Th17 Cells immunology, Interleukin-17 blood, Anesthetics, Inhalation administration & dosage, Gallbladder Neoplasms surgery, Gallbladder Neoplasms immunology, Propofol administration & dosage, Sevoflurane administration & dosage
- Abstract
There is a paucity of literature regarding the effect of anesthetic techniques on antitumor immunity, especially in gall bladder malignancies. We designed a study to compare the effect of propofol-based total intravenous anesthesia and sevoflurane-based general anesthesia-on antitumor immunity, including tumor growth factor-β (TGF-β), T-helper cell profile, and inflammatory markers. A pilot prospective randomized trial was conducted in 64 patients undergoing surgery for gall bladder malignancy under general anesthesia in a tertiary specialty cancer hospital. Adult cancer patients of ASA physical status I-III fulfilling the inclusion criteria were randomized to either group S (sevoflurane-based general anesthesia) or group T (propofol-based total intravenous anesthesia). Preoperative (morning of surgery) and postoperative (24 h and 1 month after surgery) blood samples were obtained. Demographic profile and preoperative parameters were comparable between both groups. There was a statistically significant difference in the postoperative value of TGF-β (higher in group T). There was a statistically significant difference in postoperative interleukin-17A value (indicative of TH17 cells), and it was found to be higher in group S. Propofol-based TIVA increases serum TGF-β levels. At the same time, Sevoflurane modulates T-helper cells-based immunity to increase TH17 cells in patients with gall bladder cancer. Multiple larger studies will be required to validate the results and provide useful recommendations., (© 2024 UICC.)
- Published
- 2025
- Full Text
- View/download PDF